Related Experiment Video
Updated: Aug 14, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Delayed hyperenhancement in a case of Takotsubo cardiomyopathy
Dariusch Haghi1, Stephan Fluechter, Tim Suselbeck
1Medical Department, University Hospital Mannheim, Mannheim, Germany. dariush.haghi@med.ma.uni-heidelberg.de
Insights
Takotsubo cardiomyopathy (TTC) is a heart condition with transient left ventricular dysfunction. This case study shows a rare instance of subendocardial delayed hyperenhancement on cardiac MRI in a TTC patient, which resolved over time.
Area of Science:
- Cardiology
- Cardiovascular Imaging
Background:
- Takotsubo cardiomyopathy (TTC) presents as acute, transient left ventricular dysfunction without coronary stenosis.
- Contrast-enhanced cardiovascular magnetic resonance (CMR) aids in TTC diagnosis.
- Delayed hyperenhancement on CMR typically indicates inflammation or fibrosis, and is usually absent in TTC.
Observation:
- A 46-year-old woman with TTC exhibited extensive apical and midventricular akinesia.
- Gadolinium-enhanced CMR revealed a small area of subendocardial delayed hyperenhancement in the affected regions.
- Follow-up CMR after 6 weeks showed complete resolution of wall motion abnormalities and persistent, identical subendocardial delayed hyperenhancement.
Findings:
- The presence of subendocardial delayed hyperenhancement in TTC is rare.
- This finding, typically associated with myocardial injury, resolved concurrently with the clinical and functional recovery in this TTC case.
- The persistence of the enhancement pattern despite wall motion recovery suggests a potential non-infarct-related myocardial substrate.
Implications:
- This case challenges the typical understanding of delayed hyperenhancement in TTC.
- It suggests that subendocardial enhancement in TTC may not always represent irreversible myocardial fibrosis or active inflammation.
- Further research is needed to elucidate the exact nature and significance of delayed hyperenhancement in Takotsubo cardiomyopathy.
Abstract:
Takotsubo cardiomyopathy (TTC) consists of an acute onset of transient akinesia of various parts of the left ventricle (apex and mid in classical TTC, mid and base in the variant form), without significant coronary artery stenosis, often accompanied by chest pain, dynamic reversible ST-T segment abnormalities and elevation of cardiac enzymes disproportionate to the extent of akinesia. Contrast-enhanced cardiovascular magnetic resonance (CMR) is a useful adjunct in the diagnostic work up of patients with TTC. Delayed hyperenhancement on gadolinium-enhanced CMR, which is indicative of active inflammation (e.g. myocarditis) or myocardial fibrosis (e.g. myocardial infarction), is usually absent in patients with TTC. In this report we present the case of a 46-years old women with TTC who had an extensive area of apical and midventricular akinesia and in whom gadolinium-enhanced CMR demonstrated a small area of subendocardial delayed hyperenhancement. A gadolinium-enhanced CMR performed 6 weeks later exhibited complete reversal of all wall motion abnormalities and an identical area of subendocardial delayed hyperenhancement.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
